original ) (raw )Do female age and body weight modify the effect of individualizedFSHdosing inIVF/ICSItreatment? A secondary analysis of theOPTIMISTtrial
Petra Manger
Acta Obstetricia et Gynecologica Scandinavica, 2019
View PDFchevron_right
Effect of obesity on recombinant follicle-stimulating hormone absorption: subcutaneous versus intramuscular administration
Scott Slayden , Karen Hammond
Fertility and Sterility, 2003
View PDFchevron_right
Serum FSH Levels during IVF Cycles: A New Paradigm for Clinical Management of Ovarian Stimulation
David kulak
2021
View PDFchevron_right
Does the Value of FSH Predict Severity of Metabolic Complications in Females with POI?
michał kunicki
Journal of Clinical Medicine
View PDFchevron_right
Do female age and body weight modify the effect of individualized FSH dosing in IVF/ICSI treatment? A secondary analysis of the OPTIMIST trial
Petra Manger
Acta Obstetricia et Gynecologica Scandinavica, 2019
View PDFchevron_right
A prospective study of predictive factors of ovarian response in 'standard' IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram
Anna-maria Andersson
Human Reproduction, 2003
View PDFchevron_right
Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist
hande akbas
Reproductive Biomedicine Online, 2010
View PDFchevron_right
Treatment-Associated Serum FSH Levels in Very Poor Responders to Ovarian Stimulation
Peyman Saadat
Journal of Assisted Reproduction and Genetics, 2003
View PDFchevron_right
Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH
Nguyen Khanh Linh
Reproductive BioMedicine Online, 2013
View PDFchevron_right
Ovarian stimulation in women with high and normal body mass index: GnRH agonist versus GnRH antagonist
Donatella Caserta
Gynecological Endocrinology, 2012
View PDFchevron_right
Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study
Joop Schoemaker
Human Reproduction, 2003
View PDFchevron_right
The Effect of Recombinant LH Addition to Recombinant FSH on Assisted Reproductive Technologies Outcomes in Overweight and Obese Patients without Polycystic Ovary Syndrome
Merve Demir
Open Journal of Obstetrics and Gynecology, 2020
View PDFchevron_right
Basal FSH concentration as a predictor of IVF outcome in older women undergoing stimulation with GnRH antagonist
Angela Vitti , Maria Matteo , Luca Maria Schönauer
Reproductive BioMedicine Online, 2006
View PDFchevron_right
Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? Potential application of a nomogram based on woman's age and markers of ovarian reserve
Antonio Simone Laganà
Arch Gynecol Obstet., 2018
View PDFchevron_right
Is measurement of progesterone level prior to FSH stimulation useful in GnRH-antagonist cycles?
Suha Kilani , Michael Chapman
Human Fertility, 2015
View PDFchevron_right
Pulsatile Luteinizing Hormone Amplitude and Progesterone Metabolite Excretion Are Reduced in Obese Women
Karen Gibbs
The Journal of Clinical Endocrinology & Metabolism, 2007
View PDFchevron_right
Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial
Anu Gerweck
European Journal of Endocrinology, 2012
View PDFchevron_right
LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH
Dolors Manau
2000
View PDFchevron_right
A Preponderance of Circulating Basic Isoforms Is Associated with Decreased Plasma Half-Life and Biological to Immunological Ratio of Gonadotropin-Releasing Hormone-Releasable Luteinizing Hormone in Obese Men 1
Juan Lopez-alvarenga
The Journal of Clinical Endocrinology & Metabolism, 2000
View PDFchevron_right
Relationship of obesity-related disturbances with LH/FSH ratio among post-menopausal women in the United States
May Beydoun
Maturitas, 2012
View PDFchevron_right
Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial
Tan Vy
Human Reproduction, 2004
View PDFchevron_right
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles
Mohamed Mitwally , Michael Kruger
Fertility and Sterility, 2007
View PDFchevron_right
Clinical Study Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles
Srisailesh Vitthala
2020
View PDFchevron_right
Serum FSH Levels in Coasting Programmes on the hCG Day and Their Clinical Outcomes in IVF ± ICSI Cycles
Srisailesh Vitthala
International journal of endocrinology, 2012
View PDFchevron_right
Prognostic models for high and low ovarian response in controlled ovarian stimulation (COS) using a gonadotropin-releasing hormone (GnRH) antagonist protocol
Bernadette Mannaerts
Fertility and Sterility, 2012
View PDFchevron_right
Monthly Journal of Clinical Medicine Assessment of ovarian reserve: Anti‑Mullerian hormone versus follicle stimulating hormone
Zehra Jamil , Roha Ch
View PDFchevron_right
Gonadotropin and body mass index: high FSH levels in lean, normally cycling women
Michele Barbato
Obstetrics and Gynecology, 2000
View PDFchevron_right
Effect of Basal Gonadotropins, Prolactin and Anthropometry as Predictive Markers of Ovarian Response in Patients Seeking Assisted Reproduction
Edem Hiadzi
Trends in Medical Research, 2015
View PDFchevron_right
Effects of Aging and Estradiol Supplementation on GH Axis Dynamics in Women
Harry Lieman
Journal of Clinical Endocrinology & Metabolism, 2001
View PDFchevron_right
Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder
Arie Verhoeff
Human reproduction (Oxford, England), 2017
View PDFchevron_right
ACTH stimulation test in lean polycystic ovary syndrome patients with insulin resistance
Yeşim Uncu
Fertility and Sterility, 2007
View PDFchevron_right
Predictive parameters for ovarian response to hyperstimulation with exogenous gonadotropins after suppression of gonadotropin secretion of the pituitary using a long-acting GnRH agonist
Christian Geyter
European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
View PDFchevron_right
Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity
Frank Stanczyk
Contraception, 2009
View PDFchevron_right
Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis
Paul Seed
Human Reproduction, 2003
View PDFchevron_right
rFSH in medically assisted procreation: Evidence for ovarian follicular hyperplasia and interest of mass spectrometry to measure 17-hydroxyprogesterone and Δ4-androstenedione in serum
Najiba LAHLOU
Molecular and Cellular Endocrinology, 2017
View PDFchevron_right